ArticleJournal of surgical case reports2026
Case report of a huge adrenal pseudocystic tumour with dopamine secretion: treatment paradigm from a very rare case.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pheochromocytomas and extra-adrenal paragangliomas are rare neuroendocrine tumors typically characterized by excess secretion of epinephrine and/or norepinephrine. Dopamine secreting tumors are even more uncommon and predominantly extra-adrenal, with only a few solid adrenal 'dopaminomas' reported. To the best of our knowledge, we present the first case of a giant right adrenal pseudocystic tumor with autonomous dopamine secretion, incidentally discovered on computed tomography. The lesion was successfully excised via a 3-trocar posterior retroperitoneoscopic adrenalectomy, with an uneventful postoperative course. The patient, previously misdiagnosed with primary hypertension and sinus tachycardia, experienced complete resolution of cardiovascular symptoms postoperatively and discontinued antihypertensives and the b-blocker. Postoperative normalization of dopamine levels confirmed the tumor as the origin of the excess secretion. This case highlights the potential for dopamine-induced secondary hypertension and tachycardia, emphasizing the importance of including dopamine assays in the routine hormonal evaluation of adrenal masses, particularly when large or associated with hypertension and/or tachycardia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.